Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. P. Laubach
CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Investigational Agents in Immunotherapy: A New Horizon for the Treatment of Multiple Myeloma
British Journal of Haematology
Hematology
CD38-driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma
Cancer Research
Cancer Research
Oncology
Lipid Raft-Targeted Therapy in Multiple Myeloma
Oncogene
Cancer Research
Genetics
Molecular Biology
Carfilzomib for Relapsed or Refractory Multiple Myeloma
The Lancet Oncology
Oncology
Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma
European Journal of Medical Research
Medicine
Mechanism of Action of a New Anti-Cd38 Antibody: Enhancing Myeloma Immunotherapy
Clinical Cancer Research
Cancer Research
Oncology
The Mechanism of Action of the Anti-Cd38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Retreatment With Bendamustine-Bortezomib-Dexamethasone in a Patient With Relapsed/Refractory Multiple Myeloma
Case Reports in Hematology